retatrutide clinical trials retatrutide UK: 2026 Trial & Approval Guide – Trim Trial of next-gen weight-loss drug

Seek emergency medical care immediately if you experience a rash, itching, swelling of the face or throat, difficulty breathing, or a rapid heartbeat

doi: 10.3389/fendo.2021.678055 (3) Wootten D, et al

This is the step most people rush, and rushing it is the most common cause of leakage or an incomplete dose

So happy I never have to try and get myself to the pharmacy anymore

Most pens only go as low as 0.25 mg increments or have fixed dose options

Key outcomes: Mean weight loss: 14.9% (vs 2.4% placebo) 86.4% of participants achieved 5% loss (vs 31.5% placebo) 50.5% achieved 15% loss (vs 4.9% placebo) SELECT (Lincoff et al., NEJM 2023) added the cardiovascular signature: in 17,604 non-diabetic adults with prior CV history, semaglutide 2.4 mg reduced MACE (CV death, MI, stroke) by 20% over 3 years